Towards the development of activity-based probes for detection of lysine-specific demethylase-1 activity

被引：9
|
作者：
Ourailidou, Maria E. [1 ]
Lenoci, Alessia [2 ]
Zwergel, Clemens [2 ]
Rotili, Dante [2 ]
Mai, Antonello [2 ,3 ]
Dekker, Frank J. [1 ]
机构：
[1] Univ Groningen, Groningen Res Inst Pharm, Dept Chem & Pharmaceut Biol, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands
[2] Sapienza Univ, Dept Drug Chem & Technol, Ple A Moro 5, I-00185 Rome, Italy
[3] Sapienza Univ, Cenci Bolognetti Fdn, Pasteur Inst, Ple A Moro 5, I-00185 Rome, Italy
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2017年 / 25卷 / 03期
基金：
欧洲研究理事会;
关键词：
Lysine demethylation; Tumorigenesis; Tranylcypromine; Irreversible inhibition; Enzyme labeling; LSD1 HISTONE DEMETHYLASE; THERAPEUTIC STRATEGY; BIOLOGICAL-ACTIVITY; STRUCTURAL BASIS; HDAC INHIBITORS; PROTEIN; DERIVATIVES; TRANYLCYPROMINE; TRANS-2-PHENYLCYCLOPROPYLAMINE; MECHANISMS;
D O I：
10.1016/j.bmc.2016.11.043
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The implications of lysine-specific demethylase-1 (LSD1) in tumorigenesis have urged scientists to develop diagnostic tools in order to explore the function of this enzyme. In this work, we present our efforts on the development of tranylcypromine (TCP)-based functionalized probes for activity -based protein profiling (ABPP) of LSD1 activity. Biotinylated forms of selected compounds enabled dose-dependent enzyme labeling of recombinant LSD1. However, treatment with LSD1 inhibitors did not clearly reduce the LSD1 labeling efficiency thus indicating that labeling using these probes is not activity dependent. This calls for alternative strategies to develop probes for ABPP of the enzyme LSD1. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码：847 / 856
页数：10
相关论文
共 50 条
  • [21] Lysine-Specific Demethylase 1 (LSD1) Inhibitors: Peptides as an Emerging Class of Therapeutics
    Baby, Stephin
    Shinde, Suchita Dattatray
    Kulkarni, Neeraj
    Sahu, Bichismita
    ACS CHEMICAL BIOLOGY, 2023, 18 (10) : 2144 - 2155
  • [22] Catalytic Mechanism Investigation of Lysine-Specific Demethylase 1 (LSD1): A Computational Study
    Kong, Xiangqian
    Ouyang, Sisheng
    Liang, Zhongjie
    Lu, Junyan
    Chen, Liang
    Shen, Bairong
    Li, Donghai
    Zheng, Mingyue
    Li, Keqin Kathy
    Luo, Cheng
    Jiang, Hualiang
    PLOS ONE, 2011, 6 (09):
  • [23] Structure-based design and discovery of potent and selective lysine-specific demethylase 1 (LSD1) inhibitors
    Nie, Zhe
    Shi, Lihong
    Lai, Chon
    Severin, Christophe
    Xu, Jiangchun
    Del Rosario, Joselyn R.
    Stansfield, Ryan K.
    Cho, Robert W.
    Kanouni, Toufike
    Veal, James M.
    Stafford, Jeffrey A.
    Chen, Young K.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (01) : 103 - 106
  • [24] QSAR Modeling, Molecular Docking and Molecular Dynamics Simulations Studies of Lysine-Specific Demethylase 1 (LSD1) Inhibitors as Anticancer Agents
    Abdizadeh, Rahman
    Heidarian, Esfandiar
    Hadizadeh, Farzin
    Abdizadeh, Tooba
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2021, 21 (08) : 987 - 1018
  • [25] Identification of SNAIL1 Peptide-Based Irreversible Lysine-Specific Demethylase 1-Selective Inactivators
    Itoh, Yukihiro
    Aihara, Keisuke
    Mellini, Paolo
    Tojo, Toshifumi
    Ota, Yosuke
    Tsumoto, Hiroki
    Solomon, Viswas Raja
    Zhan, Peng
    Suzuki, Miki
    Ogasawara, Daisuke
    Shigenaga, Akira
    Inokuma, Tsubasa
    Nakagawa, Hidehiko
    Miyata, Naoki
    Mizukami, Tamio
    Otaka, Akira
    Suzuki, Takayoshi
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (04) : 1531 - 1544
  • [26] The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine-specific demethylase 1
    Lin, Yiwei
    Wu, Yadi
    Li, Junlin
    Dong, Chenfang
    Ye, Xiaofeng
    Chi, Young-In
    Evers, B. Mark
    Zhou, Binhua P.
    EMBO JOURNAL, 2010, 29 (11) : 1803 - 1816
  • [27] Nonpeptidic Propargylamines as Inhibitors of Lysine Specific Demethylase 1 (LSD1) with Cellular Activity
    Schmitt, Martin L.
    Hauser, Alexander-Thomas
    Carlino, Luca
    Pippel, Martin
    Schulz-Fincke, Johannes
    Metzger, Eric
    Willmann, Dominica
    Yiu, Teresa
    Barton, Michelle
    Schuele, Roland
    Sippl, Wolfgang
    Jung, Manfred
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (18) : 7334 - 7342
  • [28] Role of Lysine-specific Demethylase 1 and Its Small Molecule Inhibitors in Glioblastoma Multiforme Therapy
    Mitra, Rangan
    Ayyannan, Senthil Raja
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022, 22 (18) : 3062 - 3085
  • [29] Fluorinated tranylcypromine analogues as inhibitors of lysine-specific demethylase 1 (LSD1, KDM1A)
    Borrello, Maria Teresa
    Schinor, Benjamin
    Bartels, Katharina
    Benelkebir, Hanae
    Pereira, Sara
    Al-Jamal, Wafa T.
    Douglas, Leon
    Duriez, Patrick J.
    Packham, Graham
    Haufe, Guenter
    Ganesan, A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (10) : 2099 - 2101
  • [30] Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021
    Song, Yihui
    Zhang, Huiqing
    Yang, Xiaoke
    Shi, Yuting
    Yu, Bin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 228
12345